Nuveen Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $3.04M | Sell |
260,697
-105,170
| -29% | -$1.23M | ﹤0.01% | 2211 |
|
2024
Q3 | $7.52M | Sell |
365,867
-499,764
| -58% | -$10.3M | ﹤0.01% | 1779 |
|
2024
Q2 | $19.4M | Buy |
865,631
+481,763
| +126% | +$10.8M | 0.01% | 1154 |
|
2024
Q1 | $10.6M | Sell |
383,868
-91,880
| -19% | -$2.53M | ﹤0.01% | 1552 |
|
2023
Q4 | $14.5M | Sell |
475,748
-32,812
| -6% | -$1M | ﹤0.01% | 1354 |
|
2023
Q3 | $16.1M | Buy |
508,560
+7,332
| +1% | +$232K | 0.01% | 1172 |
|
2023
Q2 | $20.4M | Sell |
501,228
-556,990
| -53% | -$22.7M | 0.01% | 1047 |
|
2023
Q1 | $39.4M | Buy |
1,058,218
+394,012
| +59% | +$14.7M | 0.01% | 659 |
|
2022
Q4 | $23.2M | Buy |
664,206
+272,982
| +70% | +$9.52M | 0.01% | 938 |
|
2022
Q3 | $21.9M | Sell |
391,224
-32,690
| -8% | -$1.83M | 0.01% | 950 |
|
2022
Q2 | $21.9M | Buy |
423,914
+84,420
| +25% | +$4.37M | 0.01% | 991 |
|
2022
Q1 | $23.8M | Sell |
339,494
-15,014
| -4% | -$1.05M | 0.01% | 1080 |
|
2021
Q4 | $41.9M | Sell |
354,508
-31,272
| -8% | -$3.7M | 0.01% | 775 |
|
2021
Q3 | $51.8M | Sell |
385,780
-56,977
| -13% | -$7.64M | 0.02% | 670 |
|
2021
Q2 | $71.7M | Sell |
442,757
-111,200
| -20% | -$18M | 0.02% | 592 |
|
2021
Q1 | $44.5M | Buy |
553,957
+44,722
| +9% | +$3.59M | 0.01% | 789 |
|
2020
Q4 | $27.7M | Buy |
509,235
+50,035
| +11% | +$2.72M | 0.01% | 1034 |
|
2020
Q3 | $9.13M | Buy |
459,200
+17,917
| +4% | +$356K | ﹤0.01% | 1578 |
|
2020
Q2 | $9.28M | Buy |
441,283
+144,568
| +49% | +$3.04M | ﹤0.01% | 1526 |
|
2020
Q1 | $3.63M | Sell |
296,715
-302,688
| -50% | -$3.7M | ﹤0.01% | 1888 |
|
2019
Q4 | $8.79M | Buy |
599,403
+451,102
| +304% | +$6.62M | ﹤0.01% | 1662 |
|
2019
Q3 | $1.98M | Buy |
148,301
+716
| +0.5% | +$9.56K | ﹤0.01% | 2406 |
|
2019
Q2 | $2.42M | Buy |
+147,585
| New | +$2.42M | ﹤0.01% | 2345 |
|